A clinical trial conducted in May 2025 observed patients taking either drug for 72 weeks, looking closely at their percent change in weight
MGF increased the number and size of the SVG-derived neural stem cells in culture
Secondary constipation: You experience constipation from specific causes, whether medications, underlying conditions, dietary factors, and more
Clinically, this potent effect is demonstrated by agents like semaglutide, which, in phase 2 trials, achieved MASH resolution without worsening fibrosis in a significant percentage of patients (Newsome et al., 2021
Most clinical trials of semaglutide focused on diabetes and obesity outcomes
This information will be valuable for your healthcare provider in determining whether symptoms represent panic attacks, medication side effects, or another medical condition requiring investigation